Cell transplantation could be a potential therapy for heart damage. Skeletal myoblasts have been expected to be a good cell source for autologous transplantation; however, the safety and efficacy of their transplantation are still controversial. Recent studies have revealed that skeletal muscle possesses the stem cell population that is distinct from myoblasts. To elucidate whether skeletal muscle stem cells can transdifferentiate into cardiomyocytes, we cocultured skeletal muscle cells isolated from transgenic mice expressing green fluorescent protein with cardiomyocytes of neonatal rats. Skeletal muscle-derived cells expressed cardiac-specific proteins such as cardiac troponin T and atrial natriuretic peptide as well as cardiac-enriched transcription factors such as Nkx2E (formerly called Csx/Nkx2.5) and GATA4 by coculture with cardiomyocytes. Skeletal muscle-derived cells also expressed cadherin and connexin 43 at the junctions with neighboring cardiomyocytes. Cardiomyocyte-like action potentials were recorded from beating skeletal muscle-derived cells. Treatment of nifedipine or culture in Ca 2+ -free media suppressed contraction of cardiomyocytes and inhibited skeletal muscle cells to express cardiac-specific proteins. Cyclic stretch completely restored this inhibitory effect. These results suggest that some part of skeletal muscle cells can transdifferentiate into cardiomyocytes and that direct cell-to-cell contact and contraction of neighboring cardiomyocytes are important for the transdifferentiation.
D espite the advances in medical and surgical treatment, heart failure is the major cause of morbidity and mortality in developed countries. Because myocardium has no or very little ability to regenerate, cardiac transplantation is the only treatment for end-stage heart failure. Cardiac transplantation, however, has many limitations, such as immunological rejection, arteriosclerosis, and donor shortage. As a potential alternative method, cell transplantation to myocardium has been studied for a decade. Skeletal muscle has been examined as a good candidate of cell source. Many studies have reported that the function of infarcted heart was improved by skeletal myoblasts transplantation (1) (2) (3) (4) (5) . However, implanted skeletal myoblasts were reported not to transdifferentiate into cardiomyocytes (6) , and electromechanical coupling between implanted skeletal muscle cells and resident cardiomyocytes was not observed in vivo (7) . Therefore, it is unlikely that implanted myoblasts contract synchronously with resident cardiomyocytes.
Recent studies have shown that skeletal muscle possesses stem cell populations that are distinct from myoblasts and their progenitor satellite cells (8) . Stem cells of skeletal muscle isolated as side population (SP) cells repopulated whole bone marrow in lethally irradiated mice (9, 10) . Qu-Peterson et al. and Torrente et al. purified stem cells from skeletal muscle, using different ability of adherence (11, 12) . The stem cells differentiated into hematopoietic cells, endothelial cells, neural cells, and myotubes. More recently, it has been reported that skeletal muscle contains hematopoietic stem cells and that this population repopulates the bone marrow (13, 14) .
Although the definition of skeletal muscle stem cells is not yet established, the ability of "transdifferentiation" or "plasticity" reported on skeletal muscle stem cells led us to investigate whether skeletal muscle-derived cells transdifferentiate into cardiomyocytes. Here, we show that skeletal muscle-derived cells express cardiac-specific proteins such as cardiac troponin T (cardiac TnT) and atrial natriuretic peptide (ANP) as well as cardiac-enriched transcription factors such as Nkx2E (formerly called Csx/Nkx2.5) and GATA4 when cocultured with contracting cardiomyocytes. Skeletal muscle-derived cells formed electromechanical junctions with neighboring cardiomyocytes. We also show that contraction of neighboring cardiomyocytes is necessary for this transdifferentiation. These results suggest that skeletal muscle-derived stem cells could be a good candidate for cell transplantation to the heart.
MATERIALS AND METHODS

Materials
The following antibodies were used for immunostaining: mouse monoclonal anti-cardiac troponin T (RV-C2, DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany), mouse monoclonal anti-cardiac troponin I (a generous gift from Dr. N. Toyota, Chiba University), rabbit polyclonal anti-ANP (Peninsula Laboratories, San Carlos, CA), goat polyclonal anti-GATA4, goat polyclonal anti-Nkx2E (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit polyclonal anti-connexin 43 (Zymed Laboratories, South San Francisco, CA), and mouse monoclonal anti-pan cadherin antibodies (Sigma, St. Louis, MO). Fluorescent secondary antibodies were purchased from Jackson Immuno Research Laboratory (Bar Harbor, ME). Nifedipine was purchased from Sigma.
Cell isolations
Primary cultures of cardiomyocytes were prepared from ventricles of 1-day-old Wistar rats as described previously (15) , basically according to the method of Simpson and Savion (16) . Cardiomyocytes were plated at a field density of 1×10 5 cells/cm 2 on 35-mm culture dishes containing coverslips coated with 1% gelatin or seeded into cell culture inserts (Falcon, Franklin Lakes, NJ) that were placed in the six-well plates and cultured in MEM supplemented with 5% bovine calf serum. The next day, the medium was replaced by Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and cytosine arabinofuranoside (10 µM; Sigma).
Skeletal muscle-derived cells were isolated from hind limbs of green fluorescent protein (GFP)-expressed transgenic mice (17), as described previously (18) . In brief, muscle tissues were minced smaller than 1 mm 3 and digested for a total of 45-60 min during three successive treatments with 0.05% trypsin-EDTA. The cells were collected in the supernatant after each treatment and resuspended in F-10 medium in the presence of 20% horse serum and 2.5 ng/ml bFGF. The cells were grown for 4 days in the same medium on the 2% gelatin-coated dishes. Then the medium was replaced by fresh medium supplemented with 20% FBS and cultured for 2 days. Cultured cells were harvested with 0.25% trypsin-EDTA and used for the following experiments.
Coculture of neonatal cardiomyocytes with skeletal muscle-derived cells
Neonatal cardiomyocytes were seeded first as described previously and cultured alone for 5 days. After 5 days, skeletal muscle-derived cells were seeded on cardiomyocytes at a 1:5 ratio in DMEM/M199 (4:1) supplemented with 10% horse serum and 5% FBS. The next day, the medium was replaced by DMEM supplemented with 5% horse serum. Cells were cocultured for an additional 3 days. Cells were fixed with 4% paraformaldehyde for 15 min and subjected to immunostaining. In one set of experiments, cell culture inserts were used to avoid direct cell-to-cell contact between cardiomyocytes and skeletal muscle-derived cells. The following three culture conditions were compared by immunostaining: a) Skeletal muscle-derived cells were cultured alone; mono-culture condition, b) Skeletal muscle-derived cells were seeded on cardiomyocytes as described previously (coculture condition), and c) cardimyocytes were cultured first on the cell culture inserts. Skeletal muscle-derived cells were seeded in the six-well plates, and the cell culture inserts containing cardiomyocytes were placed on them (double-chamber condition).
Immunocytochemistry
Cells were preblocked in phosphate-buffered saline (PBS) containing 2% donkey serum, 2% bovine serum albumin (BSA), and 0.2% NP-40 for 30 min. Primary antibodies were diluted by PBS containing 2% donkey serum, 2% BSA, and 0.1% NP-40 and applied overnight at 4°C. Subsequently, cells were washed three times in PBS. Cy3-or Cy5-conjugated secondary antibody was applied to visualize expression of specific proteins. Images of cells were taken by laser confocal microscopy (Radiance2000, Bio-Rad, Hercules, CA)
Action potential (AP) recording using patch-cramp techniques
APs were recorded from GFP-positive skeletal muscle-derived cells beating synchronously with neighboring cardiomyocytes in coculture. The bath (extracellular) solution contained 143 mM NaCl, 5.4 mM KCl, 0.33 mM NaH 2 PO 4 , 0.5 mM MgCl 2 , 5.5 mM glucose, 5 mM HEPES, and 1.8 mM CaCl 2 (pH 7.4). Pipettes (4-6 MΩ) filled with an internal solution containing 110 mM KOH, 20 mM KCl, 110 mM aspartate, 1 mM MgCl 2 , 5 mM HEPES-KOH, 10 mM EGTA, 5 mM ATP-K2, 5 mM K2-phosphocreatine, and 1.42 mM CaCl 2 (pH 7.4) were sealed to the cells. Electrical signals were fed into an Axopatch-1D (Axon Instruments, Union City, CA), filtered at 2 kHz, and digitized at a sampling rate of 5 kHz.
Nifedipine treatment and cyclic stretch
To examine whether contraction of cardiomyocytes is important for transdifferentiation of skeletal muscle-derived cells, we cocultured cells in the presence or absence of 5 µM nifedipine and applied passive cyclic stretch. Skeletal muscle-derived cells were cocultured with cardiomyocytes on silicone dishes (2×2 cm) coated with collagen type I (Koken, Tokyo, Japan) in the following three conditions. a) coculture without treatment, b) coculture in the presence of 5 µM nifedipine, and c) coculture with cyclic stretch in the presence of 5 µM nifedipine. Silicone dishes were mounted on a mechanical cell stimulator (Scholar Tec. Co, Osaka, Japan), which stretched the silicone membrane by 12% in length at a frequency of 60 cycles/min. The cyclic stretch was applied continuously for 48 h. Cells were fixed with 4% PFA and analyzed by immunocytochemistry. The number of GFP-positive cells that expressed cardiac-specific proteins was counted and calibrated by the total number of GFP-positive cells/4 cm 2 .
Statistical analysis
Data are presented as means ±SE. A value of P<0.05 was considered to be statistically significant. Statistical analysis was performed using one-way ANOVA, and a Student's t test was used to examine significance of difference in two groups.
RESULTS
Skeletal muscle-derived cells expressed cardiac TnT and ANP in coculture
To test whether skeletal muscle-derived cells can transdifferentiate into cardiomyocytes, we cultured skeletal muscle cells that were prepared from GFP transgenic mice with cardiac myocytes of neonatal rats and examined the expression of cardiac-specific proteins. Although the majority of GFP-positive cells did not express cardiac TnT and ANP, a few GFP-positive cells (∼0.02%) expressed cardiac TnT and ANP. Expression of cardiac TnT was first observed at day 2 of the coculture. At day 4, GFP-positive cells expressing cardiac TnT showed a fine striated pattern, indicating sarcomere formation (Fig. 1A, 1B) . ANP staining was observed at the perinuclear region at day 2 as reported previously (Fig. 1C ) (19) . Complete colocalization of GFP signal and cardiac TnT was confirmed by a merged picture of the confocal image (Fig. 1D ). The expression of these two cardiac-specific proteins in GFP-positive cells suggests that skeletal muscle-derived cells transdifferentiate into cardiomyocytes.
Skeletal muscle-derived cells expressed Nkx2E and GATA4
We next examined the expression of cardiac transcription factors Nkx2E and GATA4 in skeletal muscle-derived cells by using the coculture system. Nkx2E is a cardiac tissue-selective homeodomain protein and activates ANP gene expression (20) . GATA4 is a member of the cardiac GATA subfamily and is known to activate ANP gene promoter synergistically with Nkx2E (20) . Cells were double stained by anti-Nkx2E antibody (red, Fig. 2B ) and anti-cardiac TnT antibody (blue, Fig. 2C ). From day 1 of the coculture, there were GFP-positive cells expressing Nkx2E (Fig. 2B) . Expression of GATA4 was examined by double staining with anti-GATA4 antibody (red, Fig. 2F ) and anti-ANP antibody (blue, Fig. 2G ). From day 1 of the coculture, there were GATA4-positive skeletal muscle-derived cells. At day 2, there were skeletal muscle-derived cells that expressed both Nkx2E and cardiac TnT (Fig. 2D) as well as GATA4 and ANP (yellowish nucleus, Fig. 2H ). These results suggest that the cardiac transcription factors Nkx2E and GATA4 were expressed in skeletal muscle-derived cells 1 day earlier than cardiac TnT and ANP were.
Skeletal muscle-derived cells expressed connexin 43 and cadherin
Cadherin and connexin 43 are major adherence junction and gap junction proteins in the intercalated disk of cardiac muscle. To investigate whether transdifferentiated skeletal muscle-derived cells contact with cardiomyocytes via gap junctions and adherence junctions, we examined the expression of connexin 43 and cadherin. Cells were double stained by anti-connexin 43 antibody and cardiac TnT (Fig. 3A-D) or anti-pan-cadherin antibody and anti-ANP antibody (Fig. 3E-H) . Expression of connexin 43 was observed at the junction of cardiac TnT-expressing skeletal muscle-derived cells and neighboring cardiomyocytes (Fig.  3D) . Expression of cadherin was observed at the junction of ANP-expressing skeletal muscle-derived cells and neighboring cardiomyocytes (Fig. 3H) . However, skeletal myoblasts and skeletal myotubes expressed little connexin 43 and cadherin at the junction of neighboring cardiomyocytes, as reported previously (7). These results suggest that skeletal muscle-derived cells contact cardiomyocytes through gap junctions and adherence junctions after transdifferentiation into cardiomyocytes.
Skeletal muscle-derived cells showed cardiomyocyte-like AP
An electrophysiological study was performed on the GFP-positive skeletal muscle-derived cells that contract synchronously with neighboring cardiomyocytes. Cells were fixed immediately after electrophysiological study and subjected to immunostaining. The contracting GFP-positive cell (yellow arrow, Fig. 4A ) expressed cardiac troponin T (yellow arrow, Fig. 4B ) and demonstrated cardiomyocyte-like APs (Fig. 4C ). This AP was characterized by a relatively long AP duration and a relatively shallow resting membrane potential. These properties are consistent with the AP observed in cardiomyocytes at an early developmental stage.
Direct contact was necessary for transdifferentiation of skeletal muscle-derived cells
All of these transdifferentiated cells were adjacent to cardiomyocytes, suggesting that cell-cell contact is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes. To prove this hypothesis, we cultured skeletal muscle-derived cells in three different ways: monoculture, coculture, and double-chamber system as described in Materials and Methods. In the double-chamber system, cardiomyocytes and skeletal muscle cells were cultured separately but in the same culture media. Skeletal muscle-derived cells expressed cardiac TnT and ANP in the coculture condition (Fig. 5C ) but not in the monoculture condition or double-chamber condition (Fig. 5A , 5B). These results suggest that humoral factors are not sufficient but that direct cell-cell contact is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes.
Nifedipine treatment inhibited the transdifferentiation of skeletal muscle-derived cells, and cyclic stretch restored the inhibitory effect of nifedipine
The cultured cardiomyocytes of neonatal rats were rhythmically beating. To access whether contraction of cardiomyocytes is necessary for transdifferentiation of skeletal muscle-derived cells, we cultured the cells in the presence or absence of nifedipine. Nifedipine (5 µM) inhibited contraction of about half of cardiomyocytes, and 20 µM nifedipine stopped the beating. Nifedipine suppressed transdifferentiation of skeletal muscle-derived cells in a dose-dependent manner (Fig. 6 ). To further examine the effect of mechanical stretch on the transdifferentiation of skeletal muscle-derived cells, we cultured cells on a silicone dish and applied passive cyclic stretch (60 cycles/min) to the skeletal muscle-derived cells cocultured with cardiomyocytes whose spontaneous beating was inhibited with 5 µM nifedipine. After 48 h of treatment, cells were stained by anti-cardiac TnT antibody and anti-ANP antibody. of Nifedipine (5 µM) markedly reduced the number of cardiac TnT-positive cells compared with control, and cyclic stretch completely restored this inhibition (Fig. 6 ). These results suggest that mechanical load on the skeletal muscle-derived cells is important for the transdifferentiation of skeletal muscle-derived cells.
DISCUSSION
The present study demonstrates that skeletal muscle-derived cells show the phenotypes of cardiomyocytes when cocultured with contracting cardiomyocytes. This is demonstrated by the expression of cardiac-specific proteins, cardiac transcription factors, and adhesion and gap junction proteins in the skeletal muscle-derived cells. When skeletal muscle derived-cells were cultured without cardiomyocytes, no skeletal muscle-derived cells expressed cardiac TnT, TnI, and ANP. However, some of GFP-positive skeletal muscle-derived cells expressed cardiac TnT, TnI, and ANP in the coculture condition (Fig. 1, and data not shown) . The anti-cardiac TnT antibody does not react with adult skeletal muscle and stained specifically cardiomyocytes (21) . ANP gene is expressed from the very early stage of embryonic development, when cells are committed to the cardiac phenotype (22) . Throughout development, ANP expression is restricted to the heart but not to skeletal muscle (22, 23) . Expression of these three cardiac-specific proteins together with cardiac transcription factors that are not expressed in the skeletal muscle strongly suggests that skeletal muscle-derived cells transdifferentiated into cardiomyocytes.
We also demonstrated the expression of two cardiac transcription factors, Nkx2E and GATA4, in the skeletal muscle-derived cells. Nkx2E is a homeobox-containing gene, and its expression is highly restricted to the heart and the heart progenitor cells but not body muscle from the very early developmental stage through adulthood (24) . GATA4 is a member of the cardiac GATA subfamily, which consists of GATA4, 5, and 6. GATA4 is also not expressed in the skeletal muscle. ANP gene expression is activated by Nkx2E and GATA4 synergistically (20) . Cardiac TnT also contains potential Nkx2E binding site and GATA binding site in its promoter region (25) . Expression of GATA4 was recognized 1 day earlier than that of cardiac TnT in skeletal muscle-derived cells, suggesting that the skeletal muscle-derived cells acquire phenotype of cardiomyocytes by the transcriptional regulation of cardiac-specific genes.
N-cadherin is a major adhesion molecule that composes the adherence junction at the intercalated disc of the heart muscle. Connexin 43 is a gap junction protein and is also located at the intercalated disc. Gap junction forms a low-resistance pathway that enables rapid conduction of cardiac AP. In our study, these two proteins were clearly expressed at the border of the transdifferentiated skeletal muscle-derived cells and cardiomyocytes. APs recorded from contracting GFP-positive skeletal muscle cells that expressed cardiac troponin T had cardiomyocyte-like properties with long duration (∼300 msec) and shallow resting membrane potential (Fig. 4) . Although skeletal muscle cells could exhibit AP by twitch, AP duration has been reported to be <5 msec (26) . Therefore the AP observed in the transdifferentiated skeletal muscle-derived cell is clearly different from that observed in the skeletal muscle. These results suggest that transdifferentiated skeletal muscle-derived cells not only express cardiac-specific proteins but also exhibit cardiac electrical properties and are able to beat.
To investigate the mechanisms of transdifferentiation, we first examined whether direct cell-cell contact is needed for transdifferentiation. The double-chamber experiment revealed that direct cell-cell contact between cardiomyocytes and skeletal muscle cells is indispensable for transdifferentiation. The conditioned medium of cardiomyocytes also did not induce transdifferentiation in skeletal muscle cells (data not shown). These results suggest that direct cell-cell contact but not secretable factors is important for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes.
Mechanical stress has been shown to activate various hypertrophic responses in cardiomyocytes (27). Mechanical stress is also involved in cell differentiation such as activation of satellite cells (28) and selective differentiation of mesenchymal progenitor cells into a ligament cell lineage (29) . To test the possibility that the contraction of cocultured cardiomyocytes enhanced the transdifferentiation of skeletal muscle-derived cells, we used nifedipine, an L-type calcium channel antagonist, as well as Ca
2+
-free culture media to inhibit spontaneous beating of cardiomyocytes. Both treatments clearly reduced the number of transdifferentiated cells. Moreover, the cyclic stretching by 12% further restored this inhibition, suggesting that mechanical stress is important for transdifferentiation. Mechanical load has been reported to activate various signaling pathways through autocrine/paracrine secretable factors (30, 31) ; Ca 2+ -dependent signalings (32) ; and adhesion molecules, including integrins (33) . Although those signaling pathways are postulated to be involved in cardiomyocyte hypertrophy, little is known about their roles in cardiac differentiation. Our immunocytochemical analysis showed expression of connexin 43 between skeletal muscle-derived cells and cardiomyocytes before transdifferntiation (data not shown). Calcium influx through gap junction via spontaneous contraction or passive stretch might activate calcium signaling, including the calmodulin pathway. Stretch-activated nonselective cation channel may also play a role in activation of calcium signaling. In our preliminary study, calmodulin inhibitors reduced the number of transdifferentiated cells (unpublished results). The role of calcium signaling in transdifferentiation is under investigation in our laboratory.
Skeletal muscle has been reported to contain stem cell populations besides satellite cells (8) . Although skeletal muscle stem cells have not been purified, skeletal muscle stem cells have been shown to differentiate into various cell lineages such as hematopoietic cells, endothelial cells, neural cells, and adipocytes (9) (10) (11) (12) . We enriched the stem cell population of skeletal muscle cells by collecting the SP fraction. Cells of the SP fraction showed a much higher rate (∼10-fold) of transdifferentiation than unfractionated cells when cocultured with cardiomyocytes (data not shown). Although this is not direct evidence, it suggests that multipotent muscle-derived stem cells differentiate into cardiomyocytes. Autologous cell transplantation of skeletal myoblasts is undergoing clinical trials. However, there is little evidence that implanted skeletal muscle cells can contract with a recipient's cardiomyocytes. Our data suggest that SP cells of skeletal muscle could be a more suitable source of cell transplantation; however, SP cells are only a small fraction of skeletal muscle-derived cells and they need to be expanded for cell transplantation. Furthermore, SP cells are not a homogeneous cell fraction. We are now investigating how to more efficiently purify stem cells from skeletal muscle and how to expand them. Recently, two independent reports have demonstrated spontaneous cell fusion between embryonic stem cells and bone marrow cells or neural stem cells (34, 35) . Although heterokaryons of cardiomyocytes and fibroblasts were reported not to express cardiac phenotypes in contrast to skeletal muscle-fibroblast heterokaryons (36) , this needs further study to elucidate whether cell fusion occurs between cardiomyocytes and skeletal muscle-derived cells in the coculture system. 
